PT  - JOURNAL ARTICLE
AU  - Bittner, Dennis
ED  - Bailey, Clifford J.
TI  - Exploring the Value and Costs of Incretin-Based Therapies
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 34--35
VI  - 14
IP  - 32
4099  - http://mdc.sagepub.com/content/14/32/34.short
4100  - http://mdc.sagepub.com/content/14/32/34.full
AB  - The development of incretin-based therapies over the past decade since the approval of exenatide has opened new possibilities for the treatment of type 2 diabetes mellitus (T2DM). This article discusses the various metabolic activities of endogenous GLP-1 and DPP-4 antagonists, the side effects of incretin-based therapies, and the need for new diabetes treatments.